MedTrace Logo

Exploring Medically Perceived Benefits, Use and Interest in Psychedelics and Cannabinoids

NCT04965740 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2022-08-12

No results posted yet for this study

Summary

The primary objective of this study is to collect insights from first responders and military personnel on their need for, use of, and interest in physical and/or mental health medical marijuana or psychedelic-assisted therapy programs. These preliminary data will help to inform and guide the development of a larger patient-oriented study and the design of a clinical program geared towards enhancing therapy treatments for first responders and military personnel.

Conditions

  • PTSD
  • Anxiety
  • Anxiety Disorders
  • Depression
  • Depressive Disorder
  • Psychological
  • Psychedelic Experiences
  • Psychedelic Drug Dependence

Interventions

DRUG

Cannabis

Recreational Cannabis

Sponsors & Collaborators

  • Empower Research Inc

    lead INDUSTRY

Eligibility

Min Age
19 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-04
Primary Completion
2022-02-04
Completion
2022-02-15
FDA Drug
Yes

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04965740 on ClinicalTrials.gov